Real world evidence on the prescribing trends of glucagon-like peptide-1 agonists in UK primary care
Tools
Tools
Tools
Hinton, W, McGovern, A, van Vlymen, J, Munro, N, Whyte, MB and de Lusignan, S (2016) Real world evidence on the prescribing trends of glucagon-like peptide-1 agonists in UK primary care In: Diabetes UK Professional Conference 2016, 2016-03-02 - 2016-03-04, Scottish Exhibition and Conference Centre, Glasgow, 2-4 March 2016.
|
Text (licence)
SRI_deposit_agreement.pdf Available under License : See the attached licence file. Download (33kB) | Preview |
Abstract
Aim The use of glucagon-like peptide-1 (GLP-1) agonists in type 2 diabetes is increasing. We present a description of their current use and prescribing trends in UK primary care and compare the characteristics of people prescribed GLP-1 agonists with phase 3 trial populations.
| Item Type: | Conference or Workshop Item (Conference Poster) |
|---|---|
| Subjects : | Nutrition |
| Divisions : | Faculty of Health and Medical Sciences > School of Biosciences and Medicine > Department of Nutritional Sciences |
| Authors : | Hinton, W, McGovern, A, van Vlymen, J, Munro, N, Whyte, MB and de Lusignan, S |
| Date : | March 2016 |
| DOI : | 10.1111/dme.45_13048 |
| Copyright Disclaimer : | © 2016 John Wiley & Sons, Inc. All Rights Reserved. |
| Related URLs : | |
| Depositing User : | Symplectic Elements |
| Date Deposited : | 18 Oct 2016 10:08 |
| Last Modified : | 06 Jul 2019 05:16 |
| URI: | http://epubs.surrey.ac.uk/id/eprint/812480 |
Actions (login required)
 |
View Item |
Downloads
Downloads per month over past year